This classification also applies to All those persons remaining maintained over a partial agonist, an agonist/antagonist, or a full antagonist including oral naltrexone or depot naltrexone.Sublingual formulation is not authorised via the FDA for agony but is effective24 Transdermal and IV types are accredited for ache although not for opioid use di

Article Under Review